Pyrazolopyrazines acting on cancers via inhibition of cdk12
US-2023192700-A1 · Jun 22, 2023 · US
Buchmann Bernd is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Buchmann Bernd |
| Total patents | 15 |
| First publication | Jan 1, 2015 |
| Latest publication | Jun 22, 2023 |
Publications ranked by popularity score, then publication date.
US-2023192700-A1 · Jun 22, 2023 · US
US-2023113037-A1 · Apr 13, 2023 · US
US-11427578-B1 · Aug 30, 2022 · US
US-2022047603-A1 · Feb 17, 2022 · US
US-2020246347-A1 · Aug 6, 2020 · US
US-2017226081-A1 · Aug 10, 2017 · US
US-2017210738-A1 · Jul 27, 2017 · US
US-9655887-B2 · May 23, 2017 · US
US-2017037028-A1 · Feb 9, 2017 · US
US-9394309-B2 · Jul 19, 2016 · US
Latest publications not already listed above.
US-2016089364-A1 · Mar 31, 2016 · US
US-2016009725-A1 · Jan 14, 2016 · US
US-2015376196-A1 · Dec 31, 2015 · US
US-9062041-B2 · Jun 23, 2015 · US
US-2015005288-A1 · Jan 1, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Pharma AG | 12 |
| Bayer Ag | 4 |
| Deutsches Krebsforsch | 4 |
| Bayer Ip Gmbh | 3 |
| Deutsches Krebsforschungszentrum Heidelberg | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 12 |
| A61P43/00 | 7 |
| A61K31/5377 | 7 |
| A61P35/02 | 6 |
| A61P29/00 | 6 |